Media Room

Welcome to our Media Room.

This page is intended for media-related inquiries and we will be happy to assist and provide current and historical news as well as new developments.

Latest News

Contact

	Jerusalem, Israel, May 6, 2008 TEVA REPORTS FIRST QUARTER 2008 RESULTS
	Jerusalem, Israel, April 30, 2008 Teva Announces Global In-Market First Quarter Sales Of Copaxone® Increased 35% To $542 Million
	Jerusalem, Israel, April 28, 2008 Teva Announces Approval Of Generic Flolan® For Injection

Ayala Miller

Director, Corporate Communications
Teva Pharmaceutical Industries Ltd.

Denise Bradley

Director, Communications & Community
Relations
Teva North America.

	Tel: +1-215-5918974
	denise.bradley@tevausa.com